- Home
- EVAX vs QMMM Comparison
EVAX vs QMMM Comparison
Compare EVAX & QMMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- QMMM
- Stock Information
- Founded
- EVAX 2008
- QMMM 2005
- Country
- EVAX Denmark
- QMMM Hong Kong
- Employees
- EVAX N/A
- QMMM N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- QMMM
- Sector
- EVAX Health Care
- QMMM
- Exchange
- EVAX Nasdaq
- QMMM NYSE
- Market Cap
- EVAX 16.3M
- QMMM 13.3M
- IPO Year
- EVAX 2021
- QMMM 2024
- Fundamental
- Price
- EVAX $1.69
- QMMM $0.93
- Analyst Decision
- EVAX Strong Buy
- QMMM
- Analyst Count
- EVAX 2
- QMMM 0
- Target Price
- EVAX $10.00
- QMMM N/A
- AVG Volume (30 Days)
- EVAX 65.8K
- QMMM 1.1M
- Earning Date
- EVAX 05-27-2025
- QMMM 04-08-2025
- Dividend Yield
- EVAX N/A
- QMMM N/A
- EPS Growth
- EVAX N/A
- QMMM N/A
- EPS
- EVAX N/A
- QMMM N/A
- Revenue
- EVAX $3,344,000.00
- QMMM $2,698,229.00
- Revenue This Year
- EVAX $102.45
- QMMM N/A
- Revenue Next Year
- EVAX $200.44
- QMMM N/A
- P/E Ratio
- EVAX N/A
- QMMM N/A
- Revenue Growth
- EVAX 4480.82
- QMMM N/A
- 52 Week Low
- EVAX $1.61
- QMMM $0.54
- 52 Week High
- EVAX $22.05
- QMMM $13.00
- Technical
- Relative Strength Index (RSI)
- EVAX 36.47
- QMMM N/A
- Support Level
- EVAX $1.67
- QMMM N/A
- Resistance Level
- EVAX $1.97
- QMMM N/A
- Average True Range (ATR)
- EVAX 0.12
- QMMM 0.00
- MACD
- EVAX 0.04
- QMMM 0.00
- Stochastic Oscillator
- EVAX 22.22
- QMMM 0.00
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About QMMM QMMM HOLDINGS LIMITED
QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly owned subsidiaries: ManyMany Creations and Quantum Matrix. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.